Korea’s Dong-A Out-licenses DPP-4 To India’s Alkem Laboratories
This article was originally published in PharmAsia News
Executive Summary
Staggering under a tightened regulatory grip and price cuts at home, Korea’s Dong-A is trying to capture growth momentum from overseas.